A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma

NCT00039754 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Stopped business reasons

Conditions

Multiple Myeloma

Interventions

DRUG: Holmium-166-DOTMP

Sponsor

Poniard Pharmaceuticals